Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension.
Cao Kejia, Ishida Tomoka, Fang Yuxin, Shinohara Kosei, Li Xuejiao, Nagaoka Natsuko, Ohno-Matsui Kyoko, Yoshida Takeshi
AI Summary
Intravitreal resveratrol protected retinal ganglion cells in a mouse glaucoma model by reducing oxidative stress and boosting neurotrophic factors, suggesting potential as a glaucoma therapy to delay visual loss.
Abstract
Purpose
To investigate the efficacy of intravitreal administration of resveratrol (RSV) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.
Methods
Experiments were performed using adult C57BL/6JJcl mice. Polystyrene microbeads were injected into the anterior chamber to induce IOP elevation. Retinal flat-mounts and sections were assessed by immunohistochemistry to detect the expression of reactive oxygen species and acetyl-p53 in retinal ganglion cells (RGCs), brain-derived neurotrophic factor (BDNF) in Müller glial cells (MGCs), and the receptor tropomyosin receptor kinase B (TrkB) in RGCs. Light cycler real-time PCR was also used for confirming gene expression of BDNF in primary cultured MGCs exposed to RSV.
Results
Microbeads induced high IOP followed by RGC death and axon loss. Administration of RSV rescued RGCs via decreased reactive oxygen species generation and acetyl-p53 expression in RGCs and upregulated BDNF in MGCs and TrkB expression in RGCs, which exhibited a strong cytoprotective action against cell death through multiple pathways under high IOP.
Conclusions
Our data suggest that administration of RSV may delay the progress of visual dysfunction during glaucoma and may therefore have therapeutic potential.
MeSH Terms
Shields Classification
Key Concepts6
In a microbead-induced high intraocular pressure (IOP) murine model for glaucoma, microbeads induced high IOP followed by retinal ganglion cell (RGC) death and axon loss.
Administration of resveratrol (RSV) rescued retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.
Administration of resveratrol (RSV) decreased reactive oxygen species generation and acetyl-p53 expression in retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.
Administration of resveratrol (RSV) upregulated brain-derived neurotrophic factor (BDNF) in Müller glial cells (MGCs) and tropomyosin receptor kinase B (TrkB) expression in retinal ganglion cells (RGCs) in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.
Administration of resveratrol (RSV) may delay the progress of visual dysfunction during glaucoma and may therefore have therapeutic potential, based on data from a microbead-induced high intraocular pressure (IOP) murine model.
Intravitreal administration of resveratrol (RSV) was investigated for its efficacy in a microbead-induced high intraocular pressure (IOP) murine model for glaucoma.
Related Articles5
Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat.
Basic ScienceGSK840 Alleviates Retinal Neuronal Injury by Inhibiting RIPK3/MLKL-Mediated RGC Necroptosis After Ischemia/Reperfusion.
Basic ScienceApolipoprotein E-Containing Lipoproteins and LRP1 Protect From NMDA-Induced Excitotoxicity Associated With Reducing α2-Macroglobulin in Müller Glia.
Basic ScienceUse of erythropoietin in ophthalmology: a review.
ReviewTear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives.
Cross-Sectional StudyIs this article assigned to the wrong chapter(s)? Let us know.